Similar articles

• Down's syndrome and leukemia: epidemiology, genetics, cytogenetics and mechanisms of leukemogenesis.

  Fong CT, Brodeur GM. Fong CT, et al. Cancer Genet Cytogenet. 1987 Sep;28(1):55-76. doi: 10.1016/0165-4608(87)90354-2. Cancer Genet Cytogenet. 1987. PMID: 2955886 Review.
• Down's syndrome and transient leukaemia-like disease in a newborn.

  Wegelius R, Väänänen I, Koskela SL. Wegelius R, et al. Acta Paediatr Scand. 1967 May;56(3):301-6. doi: 10.1111/j.1651-2227.1967.tb15381.x. Acta Paediatr Scand. 1967. PMID: 4226708 No abstract available.
• Megakaryoblastic leukemia and Down's syndrome: a review.

  Zipursky A, Peeters M, Poon A. Zipursky A, et al. Pediatr Hematol Oncol. 1987;4(3):211-30. doi: 10.3109/08880018709141272. Pediatr Hematol Oncol. 1987. PMID: 2978961 Review.
• Hematological changes in Down's syndrome.

  Ganick DJ. Ganick DJ. Crit Rev Oncol Hematol. 1986;6(1):55-69. doi: 10.1016/s1040-8428(86)80047-6. Crit Rev Oncol Hematol. 1986. PMID: 2946491 Review.
• Congenital leukaemia in neonate with Down's syndrome.

  Prasad R, Singh R, Singh UK, Kumar R. Prasad R, et al. J Indian Med Assoc. 2003 Sep;101(9):550-1, 560. J Indian Med Assoc. 2003. PMID: 15168993 No abstract available.